Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Arch Biopartners Inc
V.ARCH
Alternate Symbol(s):
ACHFF
Technology
Scientific & Technical Instruments
Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is...
LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:ARCH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(13)
•••
C10H12N2
X
View Profile
View Bullboard History
Comment by
C10H12N2
on Jan 26, 2022 3:35am
RE:Here is the reason AGN is .04
This Message Board Will Always Be A Market For Bears
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Jan 25, 2022 3:51pm
We have solid support 3.40 to 3.60
Next we just need to hear HC approval of the Phase 3 and off we go.
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Post by
GoldenArm
on Jan 19, 2022 2:13pm
Stockhouse reports contradict themselves
I notice that the Stockhouse editorial from the 17th is completely contradicted by the 18th editorial. Goes to show there is no thought put into this just follows the hype of the day.
(75)
•••
Antonius2
X
View Profile
View Bullboard History
Post by
Antonius2
on Jan 16, 2022 1:15pm
MLK Day
Markets are closed in the US on Monday - let's see how this affects Arch stock price fluctuations interday.
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Jan 13, 2022 4:45pm
RE:RE:RE:RE:RE:When r we going to get trial results news?
I would but I don't do sugar. I'm not angry or hangry...okay I am hungry. GLTA
(121)
•••
futuregains
X
View Profile
View Bullboard History
Comment by
futuregains
on Jan 13, 2022 2:31pm
RE:RE:RE:RE:When r we going to get trial results news?
I'm aware of this info thanks. Have 2 snickers!!
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Jan 13, 2022 11:54am
RE:RE:RE:When r we going to get trial results news?
Why don't you admit you can't to research? I'm going to help just this once. TORONTO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch Biopartners”, “Arch” or the “Company”)
...more
(121)
•••
futuregains
X
View Profile
View Bullboard History
Comment by
futuregains
on Jan 13, 2022 8:15am
RE:RE:When r we going to get trial results news?
I was referring to the catco trial.
(9)
•••
Riverfolk
X
View Profile
View Bullboard History
Comment by
Riverfolk
on Jan 12, 2022 9:48pm
RE:When r we going to get trial results news?
The company announced trial results in early December, at that time it was reviewed by a third party (CATCO) and approved in a fully funded phase III trial. This review was a third party scientific
...more
(121)
•••
futuregains
X
View Profile
View Bullboard History
Comment by
futuregains
on Jan 12, 2022 4:18pm
RE:RE:When r we going to get trial results news?
Thanks.
(75)
•••
Antonius2
X
View Profile
View Bullboard History
Comment by
Antonius2
on Jan 12, 2022 2:58pm
RE:When r we going to get trial results news?
Everything in the world is delayed re: Covid (I have just received mailed Christmas cards from Europe). I expect an announcement 1st Q of 2022. Patience.......
(121)
•••
futuregains
X
View Profile
View Bullboard History
Comment by
futuregains
on Jan 12, 2022 1:07pm
RE:RE:When r we going to get trial results news?
Someone needs a Snickers!!!
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Jan 12, 2022 10:25am
RE:When r we going to get trial results news?
Why are you asking us? Ask the company and let us know.
(121)
•••
futuregains
X
View Profile
View Bullboard History
Post by
futuregains
on Jan 11, 2022 4:23pm
When r we going to get trial results news?
Anybody have thoughts on this?
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >